Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
CDX-527 for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
Atlanta, Georgia
This trial is testing a new cancer treatment on patients with selected solid tumors. The treatment will be given in escalating doses to determine a safe and effective dose. The trial will be conducted at multiple center and the treatment's effectiveness will be expanded.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.